Cargando…

Point estimation following a two-stage group sequential trial

Repeated testing in a group sequential trial can result in bias in the maximum likelihood estimate of the unknown parameter of interest. Many authors have therefore proposed adjusted point estimation procedures, which attempt to reduce such bias. Here, we describe nine possible point estimators with...

Descripción completa

Detalles Bibliográficos
Autores principales: Grayling, Michael J, Wason, James MS
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896306/
https://www.ncbi.nlm.nih.gov/pubmed/36384365
http://dx.doi.org/10.1177/09622802221137745
_version_ 1784882033746509824
author Grayling, Michael J
Wason, James MS
author_facet Grayling, Michael J
Wason, James MS
author_sort Grayling, Michael J
collection PubMed
description Repeated testing in a group sequential trial can result in bias in the maximum likelihood estimate of the unknown parameter of interest. Many authors have therefore proposed adjusted point estimation procedures, which attempt to reduce such bias. Here, we describe nine possible point estimators within a common general framework for a two-stage group sequential trial. We then contrast their performance in five example trial settings, examining their conditional and marginal biases and residual mean square error. By focusing on the case of a trial with a single interim analysis, additional new results aiding the determination of the estimators are given. Our findings demonstrate that the uniform minimum variance unbiased estimator, whilst being marginally unbiased, often has large conditional bias and residual mean square error. If one is concerned solely about inference on progression to the second trial stage, the conditional uniform minimum variance unbiased estimator may be preferred. Two estimators, termed mean adjusted estimators, which attempt to reduce the marginal bias, arguably perform best in terms of the marginal residual mean square error. In all, one should choose an estimator accounting for its conditional and marginal biases and residual mean square error; the most suitable estimator will depend on relative desires to minimise each of these factors. If one cares solely about the conditional and marginal biases, the conditional maximum likelihood estimate may be preferred provided lower and upper stopping boundaries are included. If the conditional and marginal residual mean square error are also of concern, two mean adjusted estimators perform well.
format Online
Article
Text
id pubmed-9896306
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-98963062023-02-04 Point estimation following a two-stage group sequential trial Grayling, Michael J Wason, James MS Stat Methods Med Res Original Research Articles Repeated testing in a group sequential trial can result in bias in the maximum likelihood estimate of the unknown parameter of interest. Many authors have therefore proposed adjusted point estimation procedures, which attempt to reduce such bias. Here, we describe nine possible point estimators within a common general framework for a two-stage group sequential trial. We then contrast their performance in five example trial settings, examining their conditional and marginal biases and residual mean square error. By focusing on the case of a trial with a single interim analysis, additional new results aiding the determination of the estimators are given. Our findings demonstrate that the uniform minimum variance unbiased estimator, whilst being marginally unbiased, often has large conditional bias and residual mean square error. If one is concerned solely about inference on progression to the second trial stage, the conditional uniform minimum variance unbiased estimator may be preferred. Two estimators, termed mean adjusted estimators, which attempt to reduce the marginal bias, arguably perform best in terms of the marginal residual mean square error. In all, one should choose an estimator accounting for its conditional and marginal biases and residual mean square error; the most suitable estimator will depend on relative desires to minimise each of these factors. If one cares solely about the conditional and marginal biases, the conditional maximum likelihood estimate may be preferred provided lower and upper stopping boundaries are included. If the conditional and marginal residual mean square error are also of concern, two mean adjusted estimators perform well. SAGE Publications 2022-11-16 2023-02 /pmc/articles/PMC9896306/ /pubmed/36384365 http://dx.doi.org/10.1177/09622802221137745 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/This article is distributed under the terms of the Creative Commons Attribution 4.0 License (https://creativecommons.org/licenses/by/4.0/) which permits any use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research Articles
Grayling, Michael J
Wason, James MS
Point estimation following a two-stage group sequential trial
title Point estimation following a two-stage group sequential trial
title_full Point estimation following a two-stage group sequential trial
title_fullStr Point estimation following a two-stage group sequential trial
title_full_unstemmed Point estimation following a two-stage group sequential trial
title_short Point estimation following a two-stage group sequential trial
title_sort point estimation following a two-stage group sequential trial
topic Original Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9896306/
https://www.ncbi.nlm.nih.gov/pubmed/36384365
http://dx.doi.org/10.1177/09622802221137745
work_keys_str_mv AT graylingmichaelj pointestimationfollowingatwostagegroupsequentialtrial
AT wasonjamesms pointestimationfollowingatwostagegroupsequentialtrial